We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Fluoroquinolone Drugs Need Boxed Warning
FDA Says Fluoroquinolone Drugs Need Boxed Warning
July 11, 2008
The FDA has asked manufacturers of fluoroquinolone antimicrobial drugs to add a boxed warning for an increased risk of tendinitis and tendon rupture to the product labeling, strengthening existing warnings.